By creating an inflammatory microenvironment within the tumor, IL‐6 and IL‐1β may promote tumor‐cell proliferation by activation of transcription factors and angiogenesis by the induction of key factors such as vascular endothelial growth factor (VEGF). This evidence concerns the gene VEGFA and neoplasm.